+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Overexpression of messenger RNA for cholecystokinin-A receptor and novel expression of messenger RNA for gastrin (cholecystokinin-B) receptor in azaserine-induced rat pancreatic carcinoma



Overexpression of messenger RNA for cholecystokinin-A receptor and novel expression of messenger RNA for gastrin (cholecystokinin-B) receptor in azaserine-induced rat pancreatic carcinoma



Carcinogenesis 14(10): 2189-2192



Using receptor binding assays, we have previously demonstrated the overexpression of the high-affinity cholecystokinin (CCK) receptor and the novel expression of the gastrin (CCK-B) receptor in the azaserine-induced rat pancreatic carcinoma DSL-6. Since cDNA of both the CCK-A receptor (classical pancreatic CCK receptor) coding region and the CCK-B receptor coding region have recently been cloned and sequenced, we investigated the expression of messenger RNA of these receptors in DSL-6 pancreatic carcinoma. Our results showed that the 32P-labelled cDNA probe of the CCK-A receptor coding region hybridized with an approximately 2.7 kb mRNA from both DSL-6 pancreatic carcinoma and normal rat pancreas. However, the relative expression of the CCK-A receptor mRNA in DSL-6 pancreatic carcinoma was approximately 8-fold of that in normal rat pancreas. The 32P-labelled cDNA probe of the CCK-B receptor coding region hybridized with an approximately 2.7 kb mRNA from DSL-6 pancreatic carcinoma; no hybridizing mRNA could be identified from normal rat pancreas. In summary, the CCK-A receptor mRNA is overexpressed approximately 8-fold and the gastrin (CCK-B) receptor mRNA is novelly expressed in DSL-6 pancreatic carcinoma as compared to normal rat pancreas. These results further confirm our previous findings based on receptor binding assays. The gene overexpression of the CCK-A receptor and the novel gene expression of the gastrin (CCK-B) receptor may be generated by alterations in gene regulation during carcinogenesis, and may play an important role in promoting tumor growth.

(PDF emailed within 0-6 h: $19.90)

Accession: 046897049

Download citation: RISBibTeXText

PMID: 8222074

DOI: 10.1093/carcin/14.10.2189


Related references

Overexpression of messenger RNA for cholecystokinin-A receptor and novel expression of messenger RNA for gastrin receptor in azaserine-induced rat pancreatic carcinoma. Gastroenterology 104(4 SUPPL ): A466, 1993

Expression of messenger RNA for the cholecystokinin-A receptor and the cholecystokinin-B receptor in human pancreatic carcinoma cell lines. Pancreas 8(6): 777, 1993

Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization. Cancer Research 52(24): 6905-6911, 1992

Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas. Oncology Research 6(9): 411-417, 1994

Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in ELSV transgenic mouse pancreatic carcinomas and dysplastic pancreas. Gastroenterology 106(4 SUPPL ): A316, 1994

Autoradiographic localization of cholecystokinin (CCK) receptor expression during the development of azaserine-induced rat pancreatic carcinoma. Pancreas 13(4): 401-406, 1996

Effects of cholecystokinin and bombesin on development of azaserine-induced pancreatic tumours in rats: modulation by the cholecystokinin receptor antagonist lorglumide. Carcinogenesis 13(9): 1525-1528, 1992

Cholecystokinin-A receptor messenger RNA expression in human pancreatic cancer. Journal of Gastrointestinal Surgery 3(2): 134-140, 1999

Differential expression of gastrin, cholecystokinin-A and cholecystokinin-B receptor mRNA in human pancreatic cancer cell lines. Scandinavian Journal of Gastroenterology 36(7): 738-743, 2001

Overexpression of cholecystokinin-B/gastrin receptor gene in the stomach of naturally occurring cholecystokinin-A receptor gene knockout rats. Digestion 59(1): 26-32, 1998

Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors. Journal of Surgical Research 58(3): 281-289, 1995

Cholecystokinin, Gastrin, Cholecystokinin/Gastrin Receptors, and Bitter Taste Receptor, TAS2R14: Trophoblast Expression and Signaling. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2019, 2019

Effect of cholecystokinin receptor antagonist on pancreatic responses to exogenous gastrin and cholecystokinin and to meal stimuli. Gastroenterology 94(4): 1014-1023, 1988

Identification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: utilization of a novel Xenopus laevis cholecystokinin receptor. Molecular Pharmacology 50(2): 436-441, 1996

Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion. European Journal of Clinical Investigation 21(5): 501-511, 1991